April 18, 2013
Düsseldorf, April 18, 2013 – A dividend of EUR 0.65 per share was approved at the Annual General Meeting of Gerresheimer AG held today in Düsseldorf. The...
More April 16, 2013
Production of components for a further Sanofi insulin pen Düsseldorf, April 16, 2013. Gerresheimer has commenced production of components for another insulin...
More April 10, 2013
First-quarter revenues up 10.4% to EUR 296.7m Adjusted EBITDA margin reaches 15.5% Net income grows by 41.7% to EUR 10.2m Adjusted earnings per share...
More February 14, 2013
Updated version March 08, 2013 Updated: 6th paragraph, last sentence New: "unlike in previous years" and "not payable tax free" Revenues rise by 11.4% (9.8%...
More December 18, 2012
Düsseldorf/New Delhi, December 18, 2012 – Gerresheimer AG, one of the world’s leading partners of the pharma and healthcare industry, today announced that it...
More October 23, 2012
Düsseldorf, October 23, 2012 – Rainer Beaujean will join the Gerresheimer AG Management Board on December 1, 2012 and assume the function of CFO on February 1,...
More October 04, 2012
Group revenues climb 9.2 percent to EUR 311.4m in Q3 2012 Third quarter adjusted EBITDA margin at 19.5 percent Net income is EUR 14.4 m, adjusted EPS is EUR...
More July 11, 2012
Group revenues rise 10.3 percent to EUR 314.0m in Q2 2012 Adjusted EBITDA increases by 4.3 percent to EUR 58.6m Net income rises to EUR 17.4m and EPS to EUR...
More July 11, 2012
Düsseldorf/Horsovsky Tyn (Czech Republic), July 11, 2012 – Gerresheimer AG, one of the world’s leading partners of the pharma and healthcare industry, is...
More 